Abstract Hemorrhage is common in brain tumors. Due to characteristic magnetic field changes induced by hemosiderin it can be detected using susceptibility weighted MRI (SWI). Its relevance to clinical syndromes is unclear.
Introduction
Intra-tumoral hemorrhage is frequent in brain tumors. Histopathological studies report on an incidence of 13 % in glioblastoma, and of 30 % in oligodendrogliomas [1] . Also brain metastases show hemorrhage which is present in up to 36 % of patients [1] . Acute hemorrhage can result in stroke-like symptoms [1] . On the other hand blood products such as iron and hemosiderin are epileptogenic which has been demonstrated in animal models and patients with vascular malformations [2] [3] [4] . Seizures are among the presenting symptoms in 30-50 % of patients with newly diagnosed tumors, and develop in up to 30 % during the post-operative course of disease [5] . A role for hemosiderin in the epileptogenesis of brain tumors has been postulated, however this was not yet addressed in detail [6] . As the above mentioned data on the incidence of intra-tumoral hemorrhage were derived from surgically obtained tissue specimen they do not allow to describe the exact intratumoral localization of hemorrhage [1] . Using susceptibility-weighted magnetic resonance imaging (SWI) it is possible to detect signal abnormalities compatible with deposits of blood products such as hemosiderin in vivo (SWI positivity, SWI pos ) [7] . This technique therefore enables to characterize SWI pos within tumors compartments as well as in the cortical and subcortical brain areas involved by the tumor. The aim of our study was to describe the incidence and distribution of SWI pos in newly diagnosed brain tumors, and to assess whether distinct patterns of SWI pos relate to the occurence of seizures.
Materials and methods

Clinical data
We retrospectively analyzed all successive patients with newly diagnosed supra-tentorial low and high grade glioma and brain metastasis which were treated at our institution between January 2009 and July 2012. As SWI pos can be found due to both the presence of blood products and calcification we excluded oligodendroglial tumors where calcification is frequently observed [7] . Patient charts were reviewed with regard to age at diagnosis of brain tumor, gender, and to the presence and semiology of seizures. Medication was recorded with particular emphasis on the administration of platelet inhibitors (aspirin, clopidogrel) or warfarin. The study was approved by the local ethics committee.
MRI data acquisition
All MR images were obtained as our routine standard diagnostic procedure in patients suspected to suffer from brain tumor using a 1.5 T Avanto or Espree scanner (Siemens Healthcare, Erlangen, Germany) using an eight channel head array coil. Among our routine MR imaging protocol of the brain which includes contrast-(Gadovist Ò ) enhanced T1-weighted images an axial SWI sequence was obtained, which is a combination of magnitude and phase images of a 3D velocity compensated gradient echo sequence. The parameters of the T2 SWI were as follows: acquisition time 4:38 min, slice thickness 2 mm, TE/ TR = 40/40 ms, 1 average and flip angle of 15°.
MRI data analysis
Pre-operative MRI scans were analyzed. SWI pos was defined using the following procedure: (1) the SWI sequences were used to detect dot-like or fine linear hypointense signal changes (SWI pos ) [8] ; (2) the minimum Intensity Projection (mIP) of the SWI sequences was reviewed to ensure that tumor signal changes are not due to flow signal from vessels; (3) the Phase imaging sequences were used to exclude calcification as a source of intratumoral SWI pos [7] . In patients with multiple brain metastases and focal epilepsy the lesion compatible with seizure semiology was chosen for assessment of SWI pos . In patients without seizures the largest brain metastasis was chosen.
As there are no established criteria to classify the degree of SWI pos we arbitrarily defined three categories: grade 0 = no SWI pos , grade I = one to five focal signal changes (either dot-like or fine linear or both), grade II = C six focal signal changes [8] .
SWI pos was also characterized by its cortical and/or subcortical localization. In patients with contrast-enhancing tumors we further assessed whether SWI pos involved the enhancing tumor area, the central hypointensity within, or the non-enhancing area outside contrast-enhancement.
Tumor size was measured on axial contrast-enhanced T1 and T2 weighted images according to the RANO criteria [9] . The two maximal perpendicular diameters were calculated on the plane showing the largest tumor diameter. In patients with multiple brain metastases the lesion which corresponded to the focal seizure semiology was chosen. In patients without seizures the largest lesion was chosen.
Statistics
We tested whether SWI pos was associated with age, treatment with platelet inhibitors or warfarin, or with tumor size. For comparison of categorial or continuous variables the Fisher's exact and Chi square test was applied. We used regression analysis to estimate whether the presence of seizures was associated with any of the clinical characteristics and imaging results. Statistical analyses were performed using SigmaStat 12 Software, SyStat, Inc., USA.
Results
We identified 105 patients (68 male, 37 female, age 59.5 ± 12.3 years (mean ± SD) with newly diagnosed brain tumors (14 low-grade glioma WHO II, 9 anaplastic glioma WHO III, 46 glioblastoma WHO IV, 36 brain metastasis) ( Table 1 ). The histopathological diagnosis was established in 91 % by partial or gross total resection, 9 % of patients were biopsied only. 87 % of patients with brain metastasis suffered from multiple lesions. 25 patients (24 %) received platelet inhibitors or warfarin for cardiovascular disorders. All glioblastomas and brain metastases showed blood-brain barrier (BBB) disruption to a variable degree as evident on pre-operative gadolinium-enhanced MRI. Two low-grade gliomas and five anaplastic gliomas showed circumscribed BBB disruption.
Frequency and distribution of SWI pos SWI pos was observed in 80 patients (76 %) and was significantly higher in glioblastoma and brain metastasis compared to the other subgroups (Chi square 9.455, p = 0.024) ( Table 1 ). The distribution of SWI pos within the tumors and with regard to subcortical location and cortical involvement is illustrated in Fig. 1 . In the majority Table 2 and is summarized in Fig. 2 . Seizure frequency and cortical involvement by tumor was highest in low-grade glioma, but cortical SWI pos was lowest in this subgroup (Fig. 2) . Vice versa 95 and 77 % of patients with glioblastoma and brain metastasis showed cortical involvement by tumor, but only 65 and 73 % showed cortical SWI pos , and 43 and 72 % of these patients experienced seizures. Testing all clinical and imaging variables we observed a significant correlation between cortical SWI pos and the presence of seizures for brain metastasis (p = 0.044), and a trend for glioblastoma (p = 0.062). Tumor SWI pos per se did not correlate with the presence of seizures. Logistic regression analysis was not possible for low-grade glioma and anaplastic astrocytoma due to the small number of patients in these subgroups. The Chi square test showed no correlation between the grade of SWI pos and the presence of seizures in all subgroups ( Table 2 ).
Discussion
Our data indicate that intra-tumoral hemorrhage as studied with susceptibility weighted MRI (SWI pos ) occurs more frequent than estimated from histopathological analysis [1] . This difference is most likely explained by sampling errors in patients who underwent partial resection or biopsy only [1] . In line with earlier reports the incidence of SWI pos exceeded 80 % in patients with glioblastoma and brain metastasis, and was low in patients with low-grade glioma [8, 10] . Therefore the presence of SWI pos on MRI may serve as a non-invasive marker of tumor malignancy. As the majority of patients with glioblastoma and brain metastasis show SWI pos within the area of BBB disruption or the central tumor core it is likely that SWI pos represents a non-specific marker of vascular leakage common to malignant brain tumors. The abnormal vascular structure in malignant gliomas is composed by immature and retiform capillaries as well as by thin walled sinusoids which may predispose to hemorrhage [11] . The origin of SWI pos in non-enhancing low grade glioma is unclear. It may be hypothesized that circumscribed SWI pos lesions (Fig. 1a) represent malignant tumor foci, and that the detection of new or enlarging SWI pos during the long-term course of low-grade tumors indicates subsequent transformation into malignant glioma. Biopsy of SWI pos tumor regions aiming at the detection of malignant glioma may unravel vascular changes within these lesions.
The overall clinical impact of hemorrhage in brain tumor patients has not been addressed in detail. Hemorrhage with stroke-like symptoms is rare and occurs in 2 to 3 % of patients [1, 12] . These clinical events are clearly less frequent than the histopathological detection of hemosiderin or SWI pos on MRI (our data) [1, 11] . Small intratumoral hemorrhage which does not result in stroke-like symptoms may be present for a hitherto unknown period of time. The evolution of the characteristic signal changes due to hemorrhage has been studied in T1 and T2 weighted MRI in various conditions including brain tumors [13, 14] . Hemorrhage induced hypointensity on T2 weighted sequences can be already observed 1 day after bleeding. As SWI are derived from T2 weighted sequences a similar behaviour of intra-tumoral SWI pos can be assumed. Intratumoral hemorrhage at the time of tumor detection may therefore be present for several days or even longer. Whether single or multiple small intra-tumoral hemorrhages contribute to persisting or increasing neurological dysfunction as e.g. in patients with amyloid angiopathy cannot be answered at the present time [15] . However cortical SWI pos in our study was significantly associated with the presence of seizures in brain metastasis, and as a trend in glioblastoma. This would be in line with studies in animals and patients with vascular malformations. Intracortical injection of hemoglobin or ferric chloride in rats leads to persisting spike activity and seizures which occur 2 to 8 days after injection [2, 3] . In patients with resected cavernoma areas with hemosiderin deposits show neuronal loss, glial proliferation and upregulation of NMDA receptor subunits to a magnitude considered to be able to promote seizures [16] . Accordingly cortical SWI pos may indicate a role for hemosiderin in the epileptogenicity of glioblastoma and brain metastasis. It has been proposed that disruption of the BBB per se induces seizures by extravasation of albumine and activation of transforming growth factor beta (TGFb) [17] . Whether this assumption is relevant to patients with brain tumors has not been investigated. In our series all patients with glioblastoma or brain metastasis showed BBB disruption, but only 43 and 72 % respectively experienced seizures. Our findings therefore do not support the view that BBB disruption or cortical involvement alone explain the epileptogenicity of these brain tumors.
Cortical tumor location represented a strong factor associated with pre-operative seizures in a series of 508 patients with low-grade glioma [18] . In line with this finding we found in our small subgroup of low-grade glioma patients a high percentage of cortical involvement, but only few tumors with SWI pos . Therefore biochemical alterations other than hemosiderin deposits may account for the occurrence of seizures in these tumors. In general changes in pH, amino acid composition, NMDA receptor status have been discussed to be involved in epileptogenesis [6] . However, all these metabolic changes cannot be assessed in a non-invasive manner in human patients. Therefore they cannot serve as in vivo markers to determine the risk for seizures. From a methodological point of view it can be assumed that SWI pos in fact reflects hemosiderin if mIP and Phase images exclude tumor calcification and flow signal. However, prospective tissue validation of SWI pos in brain tumors is required. Preliminary data of our group obtained from a retrospective series indicate a high specificity to identify hemosiderin using susceptibility weighted MRI [19] .
The limitation of our study is the small number of patients, particularly of low-grade gliomas and anaplastic astrocytomas, which however reflects their incidence in the general population and therefore in our clinical routine. Cortical SWI pos as an independent predictor of subsequent seizures should lead to re-evaluate the use of prophylactic anticonvulsants in patients showing this feature. From our results we propose to longitudinally investigate the presence and evolution of SWI pos with particular focus on glioblastoma and brain metastasis in larger patient cohorts. Several issues may contribute to hemosiderin deposits during the course of brain tumors. SWI pos is often detected after brain tumor surgery. Irradiation can result in vascular leakage and microbleeds [20, 21] . In addition hemorrhage may also result from anti-angiogenic therapy, uncontrolled tumor growth and from the appearance of new brain metastasis. In a recent study on patients with newly diagnosed brain metastasis from malignant melanoma 94 % of lesions involved the cerebral cortex, and 54 % were hemorrhagic [22] . In those patients who initially did not present with seizures the risk to develop seizures within three months after the time of the diagnosis was 17 % if no prophylactic anticonvulsants were administered. In contrast no patient treated with prophylactic anticonvulsants suffered from seizures during that period. It appears worthwhile to prospectively assess whether cortical SWI pos represents a risk factor for the occurrence of seizures, and whether cortical SWI pos determines the risk for seizure relapse once anticonvulsants are discontinued after surgery.
